Quantamental Technologies LLC Supernus Pharmaceuticals, Inc. Transaction History

Quantamental Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $238,023 - $308,213	7,958 New	7,958 $239,000
Q4 2019 Feb 14, 2020	SELL	$19.93 - $29.13 $188,717 - $275,831	-9,469 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$25.47 - $33.37 $241,175 - $315,980	9,469 New	9,469 $260,000
Q2 2019 Aug 12, 2019	SELL	$29.96 - $38.87 $193,541 - $251,100	-6,460 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$32.77 - $41.99 $191,147 - $244,927	5,833 Added 930.3%	6,460 $226,000
Q4 2018 Jan 28, 2019	BUY	$30.84 - $49.51 $19,336 - $31,042	627 New	627 $21,000

286

60.7M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.14B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.